News from REMEDY

On Tuesday, May 20, REMEDY celebrated its fourth anniversary. At the same time, the center is now halfway through its eight-year period as a Research Center for Clinical Treatment (FKB).

A new KG Jebsen Center will develop a treatment that removes the cells that drive autoimmune diseases – without weakening the entire immune system. The goal is safer and more effective treatment, with fewer side effects.

Ida K. Bos-Haugen has been given a new and more influential role in Osteoarthritis Research Society International (OARSI). The news was announced at the OARSI World Congress on Osteoarthritis this year.

A Norwegian study shows that more personalized treatment can provide better disease control. Now new analyses show that the healthcare system can also save money.

Many people with gout live with repeated, extreme pain. New Norwegian research shows that the disease can be controlled. For most people, attacks can disappear completely if they receive the right treatment.

Researchers at Diakonhjemmet Hospital are now testing the app MinUrinsyregikt. They want to find out if it works well for patients who are followed up by their GP. If you have gout and live in Norway, you can join.

After decades of research, teaching and clinical work, Professor Uhlig was honored with his own symposium at Diakonhjemmet Hospital. He now takes on the role of professor emeritus.

Are you planning to publish an article? See an overview of selected journals with no or reduced Article Processing Charge (APC).

A new study shows that rehabilitation can reduce costs for society. People with long-term health problems had a better quality of life, and sick leave decreased.

 REMEDY Research Center and the Clinic for Rheumatology, Research and Outpatient Clinic at Diakonhjemmet Hospital invite you to the free event Green Congress!

More and more people are getting osteoarthritis, but many have to wait a long time for physiotherapy. Could a training app be a good alternative?